Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data

BACKGROUND: Chronic use of inhaled anticholinergics by patients with chronic obstructive pulmonary disease (COPD) has raised long-term safety concerns, particularly cardiovascular. Glycopyrronium is a once-daily anticholinergic with greater receptor selectivity than previously available agents. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Urzo, Anthony D, Kerwin, Edward M, Chapman, Kenneth R, Decramer, Marc, DiGiovanni, Robert, D’Andrea, Peter, Hu, Huilin, Goyal, Pankaj, Altman, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541545/
https://www.ncbi.nlm.nih.gov/pubmed/26316734
http://dx.doi.org/10.2147/COPD.S81266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541545/
https://www.ncbi.nlm.nih.gov/pubmed/26316734
http://dx.doi.org/10.2147/COPD.S81266

Ejemplares similares